Chakrabarti Capital Management (CCM) is a seed stage investor investing out of an Evergreen Fund

Learn more

CCM’s healthcare portfolio is organized under the holding company, CCM Biosciences

Learn more

Expansive portfolio of first-in-class drug candidates to fulfill unmet needs

Learn more

Companion Diagnostics for Each Drug Program

Learn more

Platforms to continuously identify new drug candidates

Learn more

NORTH AMERICA

Wistar Institute
Vanderbilt University Medical School
Thomas Jefferson University
Cleveland Clinic Taussig Cancer Institute
University of California at Los Angeles
Yale University

EUROPE

University of Palermo
Italian Cystic Fibrosis Foundation

Academic Collaborations

Partnered with Scientific Thought Leaders for Distributed & Scalable Innovation Management

Learn more

crdmo

In-House Contract Research Development & Manufacturing Organisation (CRDMO) to support preclinical drug development and Chemistry, Manufacturing and Control (CMC) during trials.

Learn more

NORTH AMERICA

Mount Laurel, NJ (HQ)
Memphis, TN
Carrollton, KY
Stockertown, PA
Mobile, AL
Lansdale, PA

EUROPE

Carvin, France
Vert Le Petit, France
Pithiviers, France
Stockertown, PA
Gennevilliers, France
Vlissingen, Netherlands

ASIA

Beijing, China
Kyungju, South Korea
Rishra, India
Hyderabad, India

Global Corporate Ecosystem

Supporting End-to-End Fully Integrated Drug Development.

Spinout of a global chemicals and pharmaceuticals conglomerate with decades of top decile track record in mergers, acquisitions & growth investments.

Learn more